Inhaled corticosteroids moderate lung function decline in adults with asthma

Thorax

Volumn 61, Issue 2, 2006, Pages 93-94

  Ernst, P ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; FORCED EXPIRATORY VOLUME; HUMANS; VITAL CAPACITY;

EID: 32544454503     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.042010     Document Type: Editorial

References (24)

1. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;332:868-75.
2. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001;107:937-44.
3. Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003;361:1071-6.
4. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002;57:880-4.
5. Boushey HA, Sorkness CA, King TS, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005;352:1519-28.
6. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-200.
7. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers wild moderate to severe asthma. Eur Respir J 1999;14:892-6.
8. 1/ vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 2002;165:1480-8.
9. Covar RA, Spahn JD, Murphy JR, et al. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 2004;170:234-41.
10. Lazaar AL, Panettieri RA Jr. Is airway remodelling clinically relevant in asthma? Am J Med 2003;115:052-9.
11. Beckett PA, Howarth PH. Pharmacotherapy and airway remodelling in asthma? Thorax 2003;56:163-74.
12. Grol MH, Gerritsen J, Vonk JM, et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med 1999;160:1830-7.
13. Boulet LP, Jobin C, Milot J, et al. Five-year changes in airflow obstruction and airway responsiveness in mild to moderate asthma. Clin Invest Med 1994;17:432-42.
14. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-63.
15. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
16. Selroos O, Pietinalho A, Lofroos AB, et al. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-34.
17. Boulet LP, Turcotte H, Laviolette M, et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000;162:1308-13.
18. Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002;57:309-16.
19. Lange P, Ulrik CS, Scharling H, et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2000;61:100-4.
20. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8.
21. Dales RE, Hanley JA, Ernst P, et al. Computer modelling of measurement error in longitudinal lung function data. J Chron Dis 1987;8:769-73.
22. Ernst P, Cai B, Blais L, et al. The early course of newly diagnosed asthma. Am J Med 2002;112:44-8.
23. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999;159:1043-51.
24. Green RH, Brightling CE, Weltmann G, et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57:875-9.